(Q42766326)

6 November 2017

Chimeric Antigen Receptor Therapy for B-cell Malignancies (English)

1 reference

6 November 2017

5

Carl June

1 reference

6 November 2017

1

David L Porter

1 reference

6 November 2017

4

Bruce Levine

1 reference

6 November 2017

Michael Kalos

2

1 reference

PMC publication ID

3119397

6 November 2017

Zhaohui Zheng

series ordinal

3

1 reference

6 November 2017

1 June 2011

1 reference

6 November 2017

1 reference

6 November 2017

2

1 reference

6 November 2017

331-332

1 reference

CARs on track in the clinic

6 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119397

Immune responses to transgene and retroviral vector in patients treated with ex vivo–engineered T cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119397

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119397

Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119397

The promise and potential pitfalls of chimeric antigen receptors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119397

The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119397

Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119397

Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119397

Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21716851

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.7150/JCA.2.331

1 reference

6 November 2017

1 reference

PMC publication ID

3119397

6 November 2017

PubMed publication ID

21716851

1 reference

PMC publication ID

3119397